Market Cap

Immatics N.V. Market Capitalization:

$1.40 Billion

USD as of Jan. 1, 2026

business Immatics N.V. Company Profile

Immatics N.V. Main Stock Listing

NASDAQ: IMTX

Market Capitalization History of Immatics N.V.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Immatics N.V. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.40 B 106.93%
Jan. 1, 2025 $677.0 M -23.25%
Jan. 1, 2024 $882.1 M 31.50%
Jan. 1, 2023 $670.8 M -17.05%
Jan. 1, 2022 $808.6 M -5.08%
Jan. 1, 2021 $851.9 M -0.64%
Jan. 1, 2020 $857.5 M 9.17%
Jan. 1, 2019 $785.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Sell the task first.
Automate what repeats.
Publish a paid offer in minutes. Learn what buyers actually pay for before building agents, workflows, or services nobody buys.
Get Started Free
For AI operators, consultants, & service builders

Immatics N.V. Categories

Germany languages Healthcare languages Biotechnology
Germany Healthcare Germany Biotechnology

Stocks & Indices

Immatics N.V. has the following listings and related stock indices.


Stock: NASDAQ: IMTX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.